Detail Information
Publications
Plasma parathyroid hormone and the risk of cardiovascular mortality in the communityEmil Hagström
Uppsala Clinical Research Center, Uppsala University, Sweden
Circulation 119:2765-71. 2009..However, data on the prospective association between circulating PTH levels and cardiovascular mortality in the community are lacking...
Plasma parathyroid hormone and risk of congestive heart failure in the communityEmil Hagström
Uppsala Clinical Research Center, Uppsala University, 751 85 Uppsala, Sweden
Eur J Heart Fail 12:1186-92. 2010..Moreover, increasing PTH is associated with worse prognosis in patients with overt HF. However, the association between PTH and the development HF in the community has not been reported...
Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screeningEmil Hagström
Endocrine Unit, Department of Surgical Sciences, Uppsala University, University Hospital, SE 751 85 Uppsala, Sweden
Eur J Endocrinol 155:33-9. 2006....
Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in SwedenHakan Melhus
Department of Medical Sciences, Uppsala University, SE 75185 Uppsala, Sweden
J Clin Endocrinol Metab 95:2637-45. 2010..Blood levels of 25-hydroxyvitamin D [25(OH)D] is the generally accepted indicator of vitamin D status, but no universal reference level has been reached...
Ticagrelor versus clopidogrel in patients with acute coronary syndromesLars Wallentin
Uppsala Clinical Research Center, Uppsala, Sweden
N Engl J Med 361:1045-57. 2009..Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel...
